|
Discovery | Pre-Clinical | Phase I | Phase II | Phase III | Manufacturing |
Regulatory | EB Programs
We understand the challenges emerging biotech companies face in the quest to push the next generation of drugs to market. This is why we’ve developed several programs that recognize stand-out emerging biotech companies.
Merck recently sponsored the Startup Battle at Labiotech Refresh in Berlin. The Startup Battle is a unique occasion for Biotech Startups to show the world their awesome ideas as they pitch in front of the best audience the European Biotech has to offer. It has become a “classic” at Labiotech Refresh.
Startup Battle contestants were asked to present their work in a 5-minute pitch, followed by 10 minutes of questions from the audience and the judges. This year, there were two separate startup battles, one for the “young and wild” early-stage startups, and one for the companies that are a bit more developed. Learn more about the contestants and see who won this year’s Startup Battle!
If you would like to be part of the next
Refresh Startup Battle
stay tuned for updates about next year's event!
More information:
http://labiotech.eu/refresh
The early-stage startup battle at
Refresh 2017 was sponsored by
Unlock your molecule's potential
2018 Advance Biotech Grant ProgramBringing your molecule to market. As part of our commitment to meet the needs of the life science community, we’ve developed several programs that recognize stand-out emerging biotech companies. These programs are designed to support biotech start-ups and medium sized companies in solving their current bioprocess development challenges to bring the next generation of molecules to market.
Learn more about the advantages to work with one source on your mAb, linker/ payload supplies and conjugation services.
Review the current dynamics in the RNA therapeutics/vaccines market with a focus on process development and manufacturing strategies.
Learn more on points to consider for successful tech transfers with a focus on cGMP training requirements.
Establishing an open dialog within the biotech community....
A report from the The Economist Intelligence Unit sponsored by Merck.
This paper, which incorporates the results of a survey of 254 pharmaceutical executives from around the world and a range of interviews with industry experts, explores in detail global pharmaceutical companies' growth strategies and their plans for managing the associated risks.
Research. Development. Production.
We are a leading supplier to the global Life Science industry: solutions and services for research, development and production of biotechnology and pharmaceutical drug therapies.
